DOCS vs NBIX
Doximity vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | DOCS | NBIX |
|---|---|---|
| AI Score | 57 | 66 |
| Price | $20.90 | $166.76 |
| P/E Ratio | 20.11× | 23.66× |
| ROE | 0.2% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.9% | 1.0% |
| Debt / Equity | 0.01× | 0.10× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 43.2 | 36.6 |
| Beta | 1.293 | 0.3859 |
| Expected Upside | +27.7% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DOCS Full Analysis
NBIX Full Analysis